Correspondence 0001213900-24-093185 from China SXT Pharmaceuticals, Inc. (SXTC) (CIK 0001723980) (SXTC)
China SXT Pharmaceuticals, Inc. (SXTC) (CIK 0001723980)
Date: Nov. 1, 2024 · CIK: 0001723980 · Accession: 0001213900-24-093185
AI Filing Summary & Sentiment
File numbers found in text: 333-282776
Letter
China SXT Pharmaceuticals, Inc.
November 1, 2024
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attn: Chris Edwards
Re: China SXT Pharmaceuticals, Inc.
Registration Statement on Form F-3
Filed on October 22, 2024
File No. 333-282776
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, China SXT Pharmaceuticals, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”), be accelerated to and that the Registration Statement becomes effective at 5:00 p.m., Eastern Time, on November 4, 2024, or as soon thereafter as practicable.
Very truly yours,
China SXT Pharmaceuticals, Inc.
Show Raw Text
CORRESP
1
filename1.htm
China SXT Pharmaceuticals, Inc.
November 1, 2024
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attn: Chris Edwards
Re:
China SXT Pharmaceuticals, Inc.
Registration Statement on Form F-3
Filed on October 22, 2024
File No. 333-282776
Ladies and Gentlemen:
In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, China SXT Pharmaceuticals, Inc. hereby requests
that the effectiveness of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”), be
accelerated to and that the Registration Statement becomes effective at 5:00 p.m., Eastern Time, on November 4, 2024, or as soon thereafter
as practicable.
Very truly yours,
China SXT Pharmaceuticals, Inc.
By:
/s/ Feng Zhou
Name:
Feng Zhou
Title:
Chief Executive Officer